| |
| |
|
| Insider
Information: |
Ben-Maimon Carole |
| Relationship: |
President and CEO, Dir... |
| City: |
Hayward |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
434,868 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$947,964 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
434,868 |
|
|
| Total
Value |
$947,964 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Impax Laboratories Inc |
IPXL |
President, Global Pharm. |
2014-05-14 |
85,914 |
2011-10-28 |
0 |
Premium* |
|
|
Teligent Inc |
TLGT |
Director |
2019-05-30 |
16,000 |
|
0 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
President and CEO, Dir... |
2024-01-17 |
332,954 |
2022-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LRMR |
Larimar Therapeutics Inc |
President and CEO |
• • – |
2024-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
66,125 |
332,954 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
President and CEO |
• • – |
2023-05-17 |
4 |
B |
$3.71 |
$18,525 |
D/D |
5,000 |
266,829 |
2.81 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
President and CEO |
• • – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
205,000 |
261,829 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
President and CEO |
• • – |
2022-09-16 |
4 |
B |
$3.15 |
$100,000 |
D/D |
31,746 |
56,829 |
2.81 |
- |
|
| TLGT |
Teligent Inc |
Director |
– • – |
2019-05-30 |
4 |
B |
$0.59 |
$5,885 |
D/D |
10,000 |
16,000 |
2.39 |
- |
|
| TLGT |
Teligent Inc |
Director |
– • – |
2017-11-13 |
4 |
B |
$3.48 |
$17,409 |
D/D |
5,000 |
6,000 |
2.39 |
- |
|
| TLGT |
Teligent Inc |
Director |
– • – |
2016-03-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| IPXL |
Impax Laboratories Inc |
President, Global Pharm. |
• • – |
2014-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,000 |
85,914 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
President, Global Pharm. |
• • – |
2013-10-25 |
4 |
OE |
$18.93 |
$127,475 |
D/D |
6,734 |
62,914 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
President, Global Pharm. |
• • – |
2013-10-10 |
4 |
OE |
$18.93 |
$99,988 |
D/D |
5,282 |
56,180 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
President, Global Pharm. |
• • – |
2013-05-23 |
4 |
D |
$18.60 |
$7,421 |
D/D |
(399) |
50,898 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
President, Global Pharm. |
• • – |
2013-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
24,800 |
51,297 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
President, Global Pharm. |
• • – |
2012-10-28 |
4 |
D |
$24.34 |
$44,688 |
D/D |
(1,836) |
26,497 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
President, Global Pharm. Div. |
• – – |
2012-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,333 |
28,333 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
President, Global Pharm. Div. |
• – – |
2011-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
24,000 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
